Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The New York Headache Center is a premier medical facility specializing in the diagnosis and advanced treatment of various headache disorders and neurological conditions. Founded and directed by Dr. Alexander Mauskop, the center is recognized for its integrative approach, combining conventional pharmacological treatments with alternative therapies such as acupuncture, biofeedback, and nutritional supplementation. The center offers specialized services including Botox injections for chronic migraines, nerve blocks, and intravenous magnesium infusions. Beyond clinical practice, the New York Headache Center is actively involved in clinical research, serving as a site for trials evaluating novel migraine therapies, including CGRP inhibitors and neuromodulation devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New York Headache Center.